These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10325239)

  • 1. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes.
    Vila-Petroff MG; Younes A; Egan J; Lakatta EG; Sollott SJ
    Circ Res; 1999 May; 84(9):1020-31. PubMed ID: 10325239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes.
    Layland J; Li JM; Shah AM
    J Physiol; 2002 Apr; 540(Pt 2):457-67. PubMed ID: 11956336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nitric oxide donors, SNAP and DEA/NO, exert a negative inotropic effect in rat cardiomyocytes which is independent of cyclic GMP elevation.
    Sandirasegarane L; Diamond J
    J Mol Cell Cardiol; 1999 Apr; 31(4):799-808. PubMed ID: 10329207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NO donors potentiate the beta-adrenergic stimulation of I(Ca,L) and the muscarinic activation of I(K,ACh) in rat cardiac myocytes.
    Abi-Gerges N; Szabo G; Otero AS; Fischmeister R; Méry PF
    J Physiol; 2002 Apr; 540(Pt 2):411-24. PubMed ID: 11956332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y; Karmazyn M
    Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes.
    Wollert KC; Fiedler B; Gambaryan S; Smolenski A; Heineke J; Butt E; Trautwein C; Lohmann SM; Drexler H
    Hypertension; 2002 Jan; 39(1):87-92. PubMed ID: 11799084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
    Fedele E; Jin Y; Varnier G; Raiteri M
    Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the NO-cGMP pathway in the muscarinic regulation of the L-type Ca2+ current in human atrial myocytes.
    Vandecasteele G; Eschenhagen T; Fischmeister R
    J Physiol; 1998 Feb; 506 ( Pt 3)(Pt 3):653-63. PubMed ID: 9503328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential role of S-nitrosylation and the NO-cGMP-PKG pathway in cardiac contractility.
    González DR; Fernández IC; Ordenes PP; Treuer AV; Eller G; Boric MP
    Nitric Oxide; 2008 May; 18(3):157-67. PubMed ID: 18023373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes.
    Kojda G; Kottenberg K; Nix P; Schlüter KD; Piper HM; Noack E
    Circ Res; 1996 Jan; 78(1):91-101. PubMed ID: 8603511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of cGMP produced by soluble and particulate guanylyl cyclase on mouse ventricular myocytes.
    Su J; Scholz PM; Weiss HR
    Exp Biol Med (Maywood); 2005 Apr; 230(4):242-50. PubMed ID: 15792945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nitric oxide on the cyclic guanosine monophosphate (cGMP) pathway during meiosis resumption in bovine oocytes.
    Schwarz KR; Pires PR; Mesquita LG; Chiaratti MR; Leal CL
    Theriogenology; 2014 Mar; 81(4):556-64. PubMed ID: 24331454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia enhances a cGMP-independent nitric oxide relaxing mechanism in pulmonary arteries.
    Mingone CJ; Gupte SA; Iesaki T; Wolin MS
    Am J Physiol Lung Cell Mol Physiol; 2003 Aug; 285(2):L296-304. PubMed ID: 12691956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cGMP-mediated negative-feedback regulation of endothelial nitric oxide synthase expression by nitric oxide.
    Vaziri ND; Wang XQ
    Hypertension; 1999 Dec; 34(6):1237-41. PubMed ID: 10601124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide donors alter cardiomyocyte cytokine secretion and cardiac function.
    Maass DL; White J; Horton JW
    Crit Care Med; 2005 Dec; 33(12):2794-803. PubMed ID: 16352962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of hippocampal LTD requires nitric-oxide-stimulated PKG activity and Ca2+ release from cyclic ADP-ribose-sensitive stores.
    Reyes-Harde M; Potter BV; Galione A; Stanton PK
    J Neurophysiol; 1999 Sep; 82(3):1569-76. PubMed ID: 10482770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): mechanisms of contractile depression by nitric oxide.
    Joe EK; Schussheim AE; Longrois D; Mäki T; Kelly RA; Smith TW; Balligand JL
    J Mol Cell Cardiol; 1998 Feb; 30(2):303-15. PubMed ID: 9515007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
    Calderone A; Thaik CM; Takahashi N; Chang DL; Colucci WS
    J Clin Invest; 1998 Feb; 101(4):812-8. PubMed ID: 9466976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide: a trigger for classic preconditioning?
    Lochner A; Marais E; Genade S; Moolman JA
    Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H2752-65. PubMed ID: 11087230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel activation facilitated by nitric oxide in retinal ganglion cells.
    Hirooka K; Kourennyi DE; Barnes S
    J Neurophysiol; 2000 Jan; 83(1):198-206. PubMed ID: 10634867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.